New York State Psychiatric Institute: all 433 studies

Page 1 of 5. Open to participants first (25), then studies with results posted, then the rest; newest registration first within each.

• Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in SchizophreniaNot yet recruitingNCT07715253Phase 1
• Brief Intervention Addressing Stigma Among Parents of Children With Mental Health ProblemsNot yet recruitingNCT07594730Not applicable
• A PET/MRI Study of Cobenfy on Dopamine Transmission in SchizophreniaRecruitingNCT07423546Phase 1/2
• Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal ThoughtsNot yet recruitingNCT07139106Phase 4
• Helping Adults With Obsessive-Compulsive Disorder Succeed at WorkRecruitingNCT07124780Not applicable
• A Multimodal Imaging Study of Dopamine in Early PsychosisNot yet recruitingNCT06977308Phase 1
• Exercise and Olanzapine-samidorphanRecruitingNCT06740890Phase 4
• Mindfulness-Based Substance Use Prevention (MINDS-UP)Not yet recruitingNCT06593470Not applicable
• An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia NervosaNot yet recruitingNCT06518941Phase 2
• Treating Common Mental Disorders in Women in Mozambique by Addressing Intimate Partner Violence in CouplesNot yet recruitingNCT06252909Not applicable
• Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum DisorderRecruitingNCT05999240Phase 2
• Sleep Interventions and Neurocognitive OutcomesNot yet recruitingNCT05987007Not applicable
• rTMS and Cognitive-behavioral Therapy for Cocaine Use DisorderRecruitingNCT05974202Not applicable
• Effects of rTMS on Food Choice in Anorexia NervosaRecruitingNCT05918835Not applicable
• Scaling up e-Connect in Juvenile Probation SettingsRecruitingNCT05541926Not applicable
• Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil)RecruitingNCT05477901Not applicable
• Shared Decision Making for Antipsychotic MedicationsNot yet recruitingNCT05416658Not applicable
• Glutamatergic Mechanisms: Aim2RecruitingNCT05401227Phase 1
• Air Pollution and Development in the Boricua Youth StudyEnrolling by invitationNCT05368493Not applicable
• Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical TrialRecruitingNCT05208190Phase 4
• Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use DisorderRecruitingNCT05011266Phase 2/3
• Relapse Prevention and Changing Habits in Anorexia NervosaRecruitingNCT04810624Not applicable
• Computer - Based Treatment for Social Anxiety DisorderRecruitingNCT04663724Not applicable
• Clinical Trials of Multivalent Opioid Vaccine ComponentsRecruitingNCT04458545Phase 1/2
• The Role of Brief Potent Glutamatergic Modulation in Addressing Problem DrinkingRecruitingNCT04084860Phase 2
• Boricua Youth Study COVID-19 Coping Intervention StudyCompletedNCT05444881Not applicableResults posted
• A Trial of Guanfacine-er for Cannabis Use DisorderCompletedNCT05273567Phase 2Results posted
• Vaped Marijuana to Attenuate Naloxone-Precipitated WithdrawalTerminatedNCT05114460Phase 2Results posted
• Investigation of TEST (Transcranial Electric Stimulation Therapy) for Chronic PainCompletedNCT05113563Not applicableResults posted
• Culturally Centering Medications for Opioid Use Disorder With American Indian and Alaska Native CommunitiesCompletedNCT04958798Not applicableResults posted
• Leveraging Social Networks to Increase COVID-19 Testing UptakeCompletedNCT04873401Not applicableResults posted
• A Gender-Enhanced Pre-Exposure Prophylaxis (PrEP) Information-Motivational Workshop for Young South African WomenCompletedNCT04833127Phase 1Results posted
• Surmounting Withdrawal to Initiate Fast Treatment With NaltrexoneCompletedNCT04762537Not applicableResults posted
• Valacyclovir for Mild Cognitive ImpairmentCompletedNCT04710030Phase 2Results posted
• Antidepressant Response in Older Adults With Comorbid PTSD and MDDTerminatedNCT04697693Phase 4Results posted
• Safety and Efficacy of Psilocybin for Body Dysmorphic DisorderCompletedNCT04656301Phase 2Results posted
• Levodopa and Exercise for Older Adults With Depression and Psychomotor SlowingTerminatedNCT04650217Phase 4Results posted
• A Trial of "Opening Doors to Recovery" for Persons With Serious Mental IllnessesCompletedNCT04612777Not applicableResults posted
• Repeated Cannabis Administration on Experimental Pain and Abuse LiabilityCompletedNCT04576507Phase 2Results posted
• 1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)TerminatedNCT04493320Phase 4Results posted
• Use of Antiretroviral (ARV) Drug Levels in Dried Blood Spots (DBS) to Assess and Manage ART Adherence in South AfricaCompletedNCT04333498Not applicableResults posted
• Treating Self Injurious Behavior: A Novel Brain Stimulation ApproachCompletedNCT04244786Not applicableResults posted
• Eye Tracking as a Biomarker of Cannabis EffectsTerminatedNCT04100590Phase 2Results posted
• Ketamine Treatment Effects on Synaptic Plasticity in DepressionCompletedNCT04091971Phase 4Results posted
• Lofexidine for Management of Opioid Withdrawal With XR-NTX TreatmentCompletedNCT04056182Phase 2Results posted
• 18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar DisorderCompletedNCT03902613Phase 4Results posted
• An Open-Label Pilot Study of Sublocade as Treatment for Opiate Use DisorderCompletedNCT03861338Phase 1/2Results posted
• ITI-007 (Lumateperone Tosylate) for SchizophreniaTerminatedNCT03817528Phase 2Results posted
• Contact: Developing New Clinical Management StrategiesCompletedNCT03812588Phase 4Results posted
• Cannabinoids for Taxane Induced Peripheral NeuropathyTerminatedNCT03782402Phase 2Results posted
• L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older AdultsTerminatedNCT03761030Phase 4Results posted
• D-serine Augmentation of NeuroplasticityCompletedNCT03711500Phase 1/2Results posted
• Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent IndividualsTerminatedNCT03711318Phase 3Results posted
• Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCVCompletedNCT03652675Not applicableResults posted
• Lorcaserin for Cannabis Use DisorderTerminatedNCT03637842Early Phase 1Results posted
• Adapting Critical Time Intervention to Support Inpatient Medical Care TransitionTerminatedNCT03637296Not applicableResults posted
• Improving Accessibility and Personalization of CR for SchizophreniaCompletedNCT03576976Not applicableResults posted
• Evaluation of Doxazosin to Alter the Abuse of OxycodoneTerminatedNCT03415581Phase 2Results posted
• Computer-Based Treatment for Social Anxiety DisorderCompletedNCT03415022Not applicableResults posted
• A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists.CompletedNCT03389750Phase 2Results posted
• Health and Justice: A Continuum of Care for HIV and SU for Justice-Involved Young Adults (PHASE 2)CompletedNCT03369249Not applicableResults posted
• Web-based Addiction Treatment: Cultural Adaptation With American IndiansCompletedNCT03363256Not applicableResults posted
• Investigation of the NMDA Antagonist Ketamine as a Treatment for TinnitusCompletedNCT03336398Phase 2Results posted
• Glutamate Reducing Interventions in SchizophreniaCompletedNCT03321617Phase 1Results posted
• Treating Hearing Loss to Improve Mood and Cognition in Older AdultsCompletedNCT03321006Phase 4Results posted
• Evaluation of the Communities of Healing Mentorship/Support Group Program: Assessment of Preliminary EfficacyCompletedNCT03317379Not applicableResults posted
• Effects of Marijuana on Symptoms of OCDCompletedNCT03274440Phase 1/2Results posted
• Pregabalin as Treatment for Alcohol Use DisorderCompletedNCT03256253Phase 2Results posted
• Effect of Lorcaserin on Cannabis Withdrawal and Self-administrationCompletedNCT03253926Phase 1/2Results posted
• Nabilone in Cannabis Users With PTSDTerminatedNCT03251326Phase 1/2Results posted
• A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine RespondersCompletedNCT03232346Phase 3Results posted
• Pharmacogenetics of Naltrexone for Stimulant AbuseCompletedNCT03226223Phase 2Results posted
• The Anti-Inflammatory Effects of Exercise and Peanut ConsumptionTerminatedNCT03212144Not applicableResults posted
• Cognitive Training and Neuroplasticity in Mild Cognitive ImpairmentCompletedNCT03205709Not applicableResults posted
• Medication Development for Opioid and Alcohol AbuseCompletedNCT03205423Phase 2Results posted
• Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use DisorderCompletedNCT03169816Phase 2/3Results posted
• Buprenorphine as Adjunct to Outpatient Induction Onto VivitrolTerminatedNCT03113409Phase 2/3Results posted
• Family Engagement, Cross-System Linkage to Substance Use Treatment for Juvenile Probationers -- Phase 3CompletedNCT03048552Not applicableResults posted
• The Cultural Formulation Interview-Engagement AidCompletedNCT03044145Not applicableResults posted
• Are Bright Lights and Regulated Sleep Effective Treatment for Depression?CompletedNCT03010488Not applicableResults posted
• Neuroimaging in Patients Undergoing TMS for DepressionCompletedNCT02974296Not applicableResults posted
• Facilitating the Behavioral Treatment of Cannabis Use DisorderCompletedNCT02946489Phase 1Results posted
• Flavanol Augmentation for Antidepressant Non-Responsive Late Life DepressionTerminatedNCT02943096Not applicableResults posted
• Effect of Clonazepam on Cannabis Withdrawal and Relapse in Treatment-seeking PatientsCompletedNCT02913924Phase 2Results posted
• Cannabinoid Medication for Adults With OCDCompletedNCT02911324Phase 1/2Results posted
• Remediation of Auditory Recognition in Schizophrenia With tDCSCompletedNCT02869334Not applicableResults posted
• Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity DisorderCompletedNCT02803229Phase 2/3Results posted
• Brief Intervention to Reduce Fear of Public SpeakingTerminatedNCT02790736Phase 4Results posted
• Comparative Effectiveness of Adaptive Treatment Strategies for SchizophreniaCompletedNCT02775864Results posted
• A Study of L-DOPA for Depression and Slowing in Older AdultsCompletedNCT02744391Phase 4Results posted
• Neural Mechanisms of Disulfiram EffectsCompletedNCT02735577Phase 4Results posted
• Imaging the Effects of rTMS on Chronic PainTerminatedNCT02687360Not applicableResults posted
• Uncovering Neural and Immune Mechanisms of Chronic Pain in Post Treatment Lyme SyndromeTerminatedNCT02687165Not applicableResults posted
• The Effect of Glutamatergic Modulation on Cocaine Self-administrationCompletedNCT02596022Phase 2Results posted
• Gabapentin in Patients at Clinical Risk for PsychosisTerminatedNCT02557945Phase 1/2Results posted
• Glutamatergic Modulation of Disordered Alcohol UseCompletedNCT02539511Phase 2/3Results posted
• Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET ImagingCompletedNCT02473250Phase 4Results posted
• Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid DependenceCompletedNCT02437344Phase 2Results posted
• Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)CompletedNCT02422290Phase 1/2Results posted
• Overlapping Neural Circuits in Pediatric OCDCompletedNCT02421315Not applicableResults posted

← New York State Psychiatric Institute overview and focus areas